NHC

National HealthCare Corporation (NHC) is a healthcare services provider with a market cap of $2.46 billion. The company's stock is considered to be trading at a significant discount to its fair value. It is also a reliable dividend payer with a current yield of 1.62%. However, there has been significant insider selling in the past three months, and profit margins have declined compared to the previous year. The company has a good balance sheet with a low debt-to-equity ratio. The stock has outperformed the US Healthcare industry and the broader US market over the past year.

The National HealthCare Corp stock holds a sell signal from the short-term Moving Average, but a buy signal from the long-term average. There is a general buy signal in the stock giving a positive forecast. The stock is considered to be high risk with high volatility. Insider sentiment is negative, with significant open-market selling from key executives. The overall evaluation results in a strongly negative Insider Power Score. The system gives more weight to recent, high-impact sales from key executives than to routine, low-impact transactions like stock awards or option exercises.

National HealthCare Corporation (NHC) is a healthcare company with a market cap of $2.63 billion, operating in the Medical Care Facilities industry. The company provides a wide range of services, including skilled nursing, assisted and independent living, homecare, and hospice. The stock has shown significant appreciation, reaching the high point of its 52-week range. Despite strong revenue growth of 12.50%, key valuation metrics like the P/E ratio are unavailable, making valuation challenging. However, the company has a solid EPS of $6.48 and a commendable ROE of 10.12%. With over $120 million in free cash flow, NHC has the flexibility for reinvestment and dividends. The stock has a modest dividend yield of 1.51%. While there are no analyst ratings, the RSI suggests the stock might be oversold, presenting a potential buying opportunity. NHC's diverse service portfolio and long history position it well for future growth in the evolving healthcare sector.